Related Experiment Video
Updated: Jan 27, 2026

Isolation of Proximal Fluids to Investigate the Tumor Microenvironment of Pancreatic Adenocarcinoma
Published on: November 5, 2020
Microenvironment-sensing, nanocarrier-mediated delivery of combination chemotherapy for pancreatic cancer
Priyanka Ray1, Gauthami Nair2, Arnab Ghosh3,4
1Department of Coatings and Polymeric Materials, North Dakota State University, Fargo, ND, 58108, USA.
Abstract:
Limited effectiveness of Raf and MEK inhibitors has impelled the interest to use the inhibitors of Extra-cellular Receptor Kinase (ERK) pathway in combination with Gemcitabine (GEM) in pancreatic cancer. However, off-target abundance of ERK receptors, challenging physico-chemical properties, and dose-limiting toxicity of the inhibitor has presented critical challenges towards fabricating this combination amenable for clinical translation. Herein we report a pharmaceutical nanoformulation of GEM and an ERK inhibitor (SCH 772984) co-stabilized within a pH-sensing nanocarrier (NC, with a hydrodynamic diameter of 161 ± 5.0 nm). The NCs were modularly derived from a triblock, self-assembling copolymer, and were chemically conjugated with GEM and encapsulated with SCH772984 at a loading content of 20.2% and 18.3%, respectively. Through pH-mediated unfolding of the individual blocks of the copolymer, the NCs were able to control the release of encapsulated drugs, traffic through cellular membranes, engage target receptors, suppress proliferation of pancreatic cancer cells, and accumulate at disease sites. Collectively our studies showed the feasibility of co-delivery of a combination chemotherapy consisting of GEM and an ERK inhibitor from a NC platform, which can sense and respond to tumor microenvironment of pancreatic cancer setting.
Insights
This study developed a novel pH-sensing nanocarrier for co-delivering Gemcitabine (GEM) and an ERK inhibitor to treat pancreatic cancer, improving drug delivery and efficacy.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Oncology
Background:
- Limited efficacy of current pancreatic cancer treatments necessitates novel therapeutic strategies.
- Challenges in clinical translation of ERK inhibitors include off-target effects and toxicity.
- Combination therapy with Gemcitabine (GEM) and ERK inhibitors shows promise but faces delivery hurdles.
Purpose of the Study:
- To develop a pharmaceutical nanoformulation for co-delivery of GEM and an ERK inhibitor (SCH 772984).
- To create a pH-sensing nanocarrier (NC) for controlled drug release and targeted delivery in pancreatic cancer.
- To evaluate the feasibility of this combination therapy for improved pancreatic cancer treatment.
Main Methods:
- Fabrication of a pH-sensing nanocarrier (NC) from a self-assembling triblock copolymer.
- Co-stabilization of GEM (conjugated) and SCH 772984 (encapsulated) within the NC.
- Characterization of NCs (hydrodynamic diameter: 161 nm) and assessment of drug loading content (GEM: 20.2%, SCH 772984: 18.3%).
- Evaluation of pH-mediated drug release, cellular uptake, and anti-proliferative effects on pancreatic cancer cells.
Main Results:
- Successfully developed a pH-sensing NC capable of co-delivering GEM and SCH 772984.
- NCs demonstrated controlled drug release triggered by pH changes in the tumor microenvironment.
- The nanoformulation effectively suppressed pancreatic cancer cell proliferation and showed accumulation at disease sites.
- Demonstrated successful traffic through cellular membranes and engagement of target receptors.
Conclusions:
- Co-delivery of GEM and an ERK inhibitor via a pH-sensing nanocarrier is feasible for pancreatic cancer treatment.
- The developed NC platform offers a promising strategy for targeted drug delivery and overcoming challenges associated with combination chemotherapy.
- This approach holds potential for enhanced therapeutic outcomes in pancreatic cancer by responding to the tumor microenvironment.
More Related Videos
Related Concept Videos
The Sense of Self: Reflected Self-Appraisal and Social Comparison
The Tumor Microenvironment
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
Two synthetic agonists of THC,...
Introduction to Special Senses
Tactile and Chemical Senses
Receptor-mediated Endocytosis

